MIGRANAL belongs to a different
class of migraine treatment
Rapid and long-lasting migraine relief1,2
Powerful efficacy across different
Eligible* commercially insured patients
pay as little as a $5 monthly copay for
the authorized generic from the makers
Eligible* commercially insured
patients pay as little as a
$5 monthly copay for the
authorized generic from the makers of MIGRANAL
*Maximum benefits apply. For eligible commercially insured patients only. For full eligibility requirements/terms and conditions, please see Patient Savings tab above.
Help patients access MIGRANAL Nasal Spray
You are solely responsible for your interactions with that website.
MIGRANAL® (dihydroergotamine mesylate) Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura. MIGRANAL Nasal Spray is not intended for the prophylactic therapy of migraine or for the management of hemiplegic or basilar migraine.
Serious and/or life-threatening peripheral ischemia has been associated with the coadministration of DIHYDROERGOTAMINE with potent CYP3A4 inhibitors including protease inhibitors and macrolide antibiotics. Because CYP3A4 inhibition elevates the serum levels of DIHYDROERGOTAMINE, the risk for vasospasm leading to cerebral ischemia and/or ischemia of the extremities is increased. Hence, concomitant use of these medications is contraindicated.
Please click here for full Prescribing Information for MIGRANAL Nasal Spray, including Boxed Warning and Patient Information.
The information contained in this site is technical in nature and was designed specifically for healthcare professionals.
To proceed, please choose one of the following: